Skip to main content

GOLDMAN SACHS GROUP INC

Position in EWTX — Edgewise Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in EWTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$24,356,425
+$4,517,096 QoQ
Shares Held
599,469
-4.8% QoQ
Ownership
0.552%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 223 holders
Holding Since
Mar 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EWTX Over Time

Shares Held

Position Value (USD)

Derivatives in EWTX

reported options exposure · as of Dec 31, 2025
CallValue
$1,732,087
CallShares
69,800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. EWTX ranks #102 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in EWTX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $24,356,425 599,469
2026-03-31 $19,839,329 629,820
2025-12-31 $1,732,087 69,800
2025-12-31 $17,826,400 718,372
2025-09-30 $8,561,353 527,827
2025-06-30 $8,282,150 631,743
2025-03-31 $8,066,168 366,644
2024-12-31 $9,261,989 346,891
2024-09-30 $12,870,584 482,225
2024-06-30 $29,225,564 1,622,741
2024-03-31 $31,880,674 1,747,844
2023-12-31 $9,647,941 881,896
2023-09-30 $5,430,859 947,794
2023-06-30 $13,592,329 1,753,849
2023-03-31 $5,030,106 754,139
2022-12-31 $9,522,180 1,065,121
2022-09-30 $615,993 62,601
2022-06-30 $1,160,686 145,815
2022-03-31 $1,282,010 132,166
2021-12-31 $619,023 40,512
2021-03-31 $2,121,047 65,263